BJH - 2018, issue Abstract Book BHS, february 2018
S. Bonte , S. Snauwaert MD, PhD, G. Goetgeluk , B. Vandekerckhove MD, PhD, T. Kerre MD, PhD
BJH - volume 8, issue Abstract Book BHS, february 2017
S. Bonte , S. Snauwaert MD, PhD, G. Goetgeluk , B. Vandekerckhove MD, PhD, T. Kerre MD, PhD
BJH - volume 7, issue Abstract Book BHS, january 2016
S. Bonte , S. Snauwaert MD, PhD, M. Heemskerk , B. Vandekerckhove MD, PhD, T. Kerre MD, PhD
BJH - volume 7, issue Abstract Book BHS, january 2016
G. Verstichel , G. Goetgeluk , L. Martens , T. Taghon , G. Leclercq , T. Kerre MD, PhD, Y. Saeys , B. Vandekerckhove MD, PhD
BJH - volume 6, issue Abstract Book BHS, january 2015
S. Bonte , S. Snauwaert MD, PhD, G. Goetgeluk , M.H.M. Heemskerk , H. Stauss , R. Stripecke , B. Vandekerckhove MD, PhD, T. Kerre MD, PhD
BJH - volume 5, issue 4, december 2014
S. Snauwaert MD, PhD, B. Vandekerckhove MD, PhD, T. Kerre MD, PhD
This dissertation focuses on T-cell-mediated immunotherapeutic strategies for the treatment of acute myeloid leukaemia. Two major key points determine the success of adoptive T-cell therapy: the nature of the target antigen and the characteristics of the infused T-cells. We reviewed potential acute myeloid leukaemia target antigens and performed an in-depth study of the Receptor for Hyaluronic Acid Mediated Motility as a potential leukaemia associated antigen. Subsequently, an alternative immunotherapeutic strategy was studied: the in vitro generation of antigen-specific T-cells starting from T-cell receptor-transduced human haematopoietic progenitor cells.
(BELG J HEMATOL 2014;5(4):154–7)
Read moreBJH - volume 5, issue Abstract Book BHS, january 2014
Y. Van Caeneghem , R. Pourebrahimabadi , T. Laskowski , Z. Garate , A. Crane , J.C. Segovia , M. Holmes , B. Vandekerckhove MD, PhD, B. Davis
Top
